My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 817 / https://doi.org/10.3332/ecancer.2018.817

Conference Report

Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8–9 February 2018

On 8 and 9 February 2018, the IFOM-IEO campus in Milan hosted the Milan summit on Precision Medicine, which gathered clinical and translational research experts from academia, industry and regulatory bodies to discuss the state of the art of precision medicine in Europe. The meeting was pervaded by a generalised feeling of excitement for a field that is perceived to be technologically mature for the transition into clinical routine but still hampered by numerous obstacles of a methodological, ethical, regulatory and possibly cultural nature. Through lively discussions, the attendees tried to identify
realistic ways to implement a technology-rich precision approach to cancer patients.

Keywords: Genomics, Next Generation sequencing, NGS, precision medicine, targeted therapy

Loading Article Metrics ... Please wait

Related articles

Review: The current state of prostate cancer treatment in Trinidad and Tobago

Abstract | Full Article | PDF Published: 24 Apr 2018 / https://doi.org/10.3332/ecancer.2018.828

Research: Nursing intervention in women who developed lymphedema after undergoing a modified radical mastectomy: a pre-experimental study

Abstract | Full Article | PDF | Spanish Published: 19 Apr 2018 / https://doi.org/10.3332/ecancer.2018.827

Clinical Study: Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents

Abstract | Full Article | PDF Published: 11 Apr 2018 / https://doi.org/10.3332/ecancer.2018.824

Review: Risk sharing agreements, present and future

Abstract | Full Article | PDF | Portuguese Published: 10 Apr 2018 / https://doi.org/10.3332/ecancer.2018.823

Conference Report: Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18–19 January 2018, Cairo, Egypt

Abstract | Full Article | PDF Published: 22 Mar 2018 / https://doi.org/10.3332/ecancer.2018.820



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence